Clinical Trials Browser

Exanthema × 1 year × Clear all

Exanthema

NCT07426822 2026-02-24

SAFE-CAP

Phase 2 Not yet recruiting

108 enrolled

Diarrhea, Exanthema

NCT03363763 2025-12-01

Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex

Phase 2 Terminated

24 enrolled 11 charts

Erythema, Exanthema, Fibroma, Tuberous Sclerosis, Facies

NCT06399029 2025-11-19

TRUX-LST

Phase 2 Recruiting

20 enrolled

Exanthema

NCT07021495 2025-08-19

Abscess, Chronic Urticaria, Angioedema, Dermatitis, Atopic, Eczema, Erythema, Exanthema, Mycosis Fungoides, Neoplasms, Photosensitivity Disorders, Pruritus, Psoriasis, Urticaria, Hidradenitis Suppurativa, Plaque, Amyloid

Clinical Trials

TREATS

SAFE-CAP

Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex

TRUX-LST

SKINERGY